The preclinical evidence base for each component is substantial
Thus, it should be introduced under close medical supervision, taking into account food allergies and intolerances (62, 64)
Hansoh Pharma will receive an upfront payment of $112 million and is eligible to receive up to $1.9 billion in milestone payments associated with the development, regulatory approval and commercialization of the candidate, as well as royalties on sales
No provisional batch, assay, method, analyst, or release data is published in this product dossier
Clinical trials would be required to establish appropriate, safe, and effective dosing protocols for any human application of this compound
However, no studies demonstrate improvement in thyroid-specific outcomes such as antibody titers, thyroid hormone levels, or disease progression